02591.HK_Providing professional financial news and data related to 02591.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Innogen (02591.HK): Proposes On‑Market H‑Share Buy‑back of Approximately HK$50 Million

Tags：

Innogen 02591.HK

2026-08-26

Innogen-B (02591.HK): Two Contract Manufacturing Sites for Isupaglutide α Injection Obtain PIC/S GMP Certificates

Tags：

INNOGEN-B 02591.HK GMP

2026-08-03

Innogen Pharmaceutical (02591.HK): Efsubaglutide Alfa Completes First Patient Dosing in Phase Ib Teen Obesity Trial

Tags：

INNOGEN-B 02591.HK

2026-07-28

INNOGEN-B(02591.HK): Ib-stage Clinical Trial of Efsubaglutide Alfa for Adolescent Obesity Approved, Expected to Kick Off in July

Tags：

INNOGEN-B 02591.HK Clinical Trial

2026-06-22

NewTimeSpace | Under GLP-1 Competition, a Pharma Darling Falls; Innogen Pharmaceutical-B (02591.HK) Market Value Shrinks by Billions

Tags：

Innogen Pharmaceutical-B 02591.HK NewTimeSpace

2026-03-05

Scan QR Code

Download App